Hai_2016_Pak.J.Med.Sci_32_1131

Reference

Title : Increase in activity of Na+, K+-ATPase by Porphyrin compounds as treatment for Dysnatremias caused by Diabetes Mellitus - Hai_2016_Pak.J.Med.Sci_32_1131
Author(s) : Hai A , Kizilbash N
Ref : Pak J Med Sci , 32 :1131 , 2016
Abstract :

OBJECTIVE: The aim of this study was to test the action of Porphyrin compounds, Tetraphenylporphine sulfonate (TPPS), 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) Chloride (FeTPPS) and 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) nitrosyl Chloride (FeNOTPPS), on Na+, K+ -ATPase of cell membrane of erythrocytes.
METHODS: Enzymatic assays, measuring the amount of inorganic phosphate produced, were used to estimate the activity of Na+, K+-ATPase.
RESULTS: The results show that Porphyrin compounds exert an insulin-like effect on Na+, K+-ATPase. They act by increasing the activity of the membrane-bound enzyme. CONCLUSION: All the three Porphyrin compounds increased the activity of erythrocyte Na+, K+-ATPase. The exact mechanism of action of these compounds is not clear.

PubMedSearch : Hai_2016_Pak.J.Med.Sci_32_1131
PubMedID: 27882008

Related information

Citations formats

Hai A, Kizilbash N (2016)
Increase in activity of Na+, K+-ATPase by Porphyrin compounds as treatment for Dysnatremias caused by Diabetes Mellitus
Pak J Med Sci 32 :1131

Hai A, Kizilbash N (2016)
Pak J Med Sci 32 :1131